Hospital News and Research

RSS

Study reveals pathway that may help slow development of multiple myeloma

Researchers at NYU School of Medicine have identified a target for slowing the progression of multiple myeloma by using currently available drugs.

17 May 2012

Gene therapy restores movement in children bedridden with AADC

Using gene transfer techniques pioneered by University of Florida faculty, Taiwanese doctors have restored some movement in four children bedridden with a rare, life-threatening neurological disease.

17 May 2012

Fitness fanatic dad becomes research pioneer after kidney disease diagnosis

A super-fit father who rowed the distance from the Equator to the North Pole on a rowing machine has told of how his experience of kidney disease led to him becoming the first patient to take part in a groundbreaking research study run in Sheffield and Leeds.

17 May 2012

First trial to investigate new drug combination for NSCLC

Cancer Research UK's Drug Development Office has opened the first trial of a new drug combination in patients with advanced solid tumours and in a subset of patients who have non-small cell lung cancer. This trial will combine two compounds that aim to starve the tumours while simultaneously blocking cancer cell growth.

17 May 2012

VA hospital incident adds to questions about nurse skills

Registered nurses at a Manhattan Veterans Affairs hospital failed to notice a patient had become disconnected from a cardiac monitor until after his heart had stopped and he could not be revived, according to a report Monday from the VA inspector general.

17 May 2012

PCSO-524 omega-3 complex may provide benefits for joint mobility and pain

According to a recent study published in Rheumatologia, the official journal of the Institute of Rheumatology and the Polish Rheumatological Society, PCSO-524, an all natural, patented, Omega-3 fish oil extract containing DHA and EPA from the New Zealand green-lipped mussel, found in Omega XL, may provide more benefits for joint mobility and pain compared to standard fish oil.

17 May 2012

Increasing Use of Smart Pumps to help drive down “Never Events”

Increased focus on providing optimum patient care in the most cost efficient way is fuelling demand for intelligent infusion devices termed “Smart Pumps.” A report from InMedica, a division of IMS Research (recently acquired by IHS Inc. (NYSE:IHS)), on the global market for infusion pumps found that, despite market saturation in the developed countries, demand for advanced technology is being maintained; infusion pump suppliers must offer technically advanced products at competitive prices to maintain market share.

17 May 2012

CCH, BGU launch collaboration to address lack of pediatric-specific medical devices

A collaboration to address the lack of medical devices designed specifically for children is being launched by Cincinnati Children's Hospital Medical Center (CCH) in Ohio and Ben-Gurion University of the Negev (BGU) in Beer-Sheva, Israel. The goal is to improve health outcomes for children by ensuring device design that is customized to meet childrens' unique physiological differences and medical needs.

17 May 2012

Ibrutinib shows promise against CLL in the elderly

The experimental drug ibrutinib (PCI-32765) shows great promise for the treatment of elderly patients with chronic lymphocytic leukemia (CLL), according to interim findings from a clinical trial.

17 May 2012

PPCI treatment on the rise among Stent for Life Initiative participants

Life saving primary percutaneous coronary intervention (PPCI) treatment is increasing in countries participating in the Stent for Life Initiative.

17 May 2012

Chinese sFDA approves Baxter's ADVATE to treat hemophilia A

Baxter International Inc. today announced the approval of ADVATE [Recombinant Human Coagulation Factor VIII for injection] for the control and prophylaxis of bleeding episodes in individuals with hemophilia A (congenital factor VIII deficiency) in China by the State Food and Drug Administration.

From Baxter International Inc. 17 May 2012

ApolloMed net revenue increases 31.2% to $5.1M for fiscal year 2012

Apollo Medical Holdings, Inc. announced financial results for its fiscal year ended January 31, 2012.

17 May 2012

Dako, VARI partner to license, manufacture and distribute cancer diagnostics

Van Andel Research Institute (VARI) and Dako, the Danish-based, worldwide supplier of cancer diagnostic tools today announce an agreement to license, manufacture and distribute cancer diagnostics utilizing the MET4 Antibody.

17 May 2012

Combination of daclizumab and vaccine improves survival of breast cancer patients

A team from the Perelman School of Medicine and the Abramson Family Cancer Research Institute at the University of Pennsylvania found that the FDA-approved drug daclizumab improved the survival of breast cancer patients taking a cancer vaccine by 30 percent, compared to those patients not taking daclizumab.

17 May 2012

Stroke survivors from King County to share their stories during EMS Week

Hours, or even minutes, can mean the difference between life and death when someone is having a stroke. As part of Emergency Medical Services (EMS) Week from May 20-26, stroke survivors from King County will share their stories about how quick recognition of stroke symptoms and timely response and treatment through King County EMS helps patients survive and return to full health.

17 May 2012

NanoString commences second clinical study of PAM50-based breast cancer assay

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the initiation of the second clinical validation study of its PAM50-based breast cancer assay.

From NanoString Technologies 17 May 2012

Lecture discusses how negative emotions fuel cancer formation and metastasis

When it comes to cancer, there are obvious mind-body links. Stress, pessimism and other emotional factors have been proven to play a role, increasing the risk of cancer, metastasis and early mortality. This is a double-whammy for cancer patients, who must overcome anxiety from the moment they are diagnosed. In particular, stress has been shown to depress the immune system, increase inflammation and affect our bodies on the molecular level, even damaging DNA.

17 May 2012

Linkam Scientific temperature controlled warm stages chosen for sperm motility in human fertility testing

Market leaders in temperature controlled microscopy, Linkam Scientific Instruments, have been chosen by an NHS Fertility clinic as suppliers of a controlled warm stage to perform routine semen analysis at body temperature.

From Linkam Scientific Instruments 16 May 2012

Treatment in hospitals with medical fellowships improves outcome for prostate cancer radical surgery

Patients who undergo radical surgery for prostate cancer may expect better results, on average, if they're treated in accredited teaching hospitals with residency programs, and better still if the hospitals also have medical fellowships, according to a new study by Henry Ford Hospital.

16 May 2012

Most depressed patients must make multiple attempts before finding an effective antidepressant

UT Southwestern Medical Center psychiatrists are leading a national clinical trial to find biomarkers that can better predict how people suffering from depression will respond to medications so physicians eventually can personalize treatments.

16 May 2012